Releases: Shuji2022/PrCa_GWAS
Releases · Shuji2022/PrCa_GWAS
v1.0.0
Codes used in GWAS for prostate cancer. Statistically fine-mapped variants in androgen receptor binding sites identified by a trans-ethnic GWAS meta-analysis for prostate cancer can predict the future death of cancer-free subjects due to prostate cancer.